Karuna Therapeutics Inc. (KRTX)
NASDAQ: KRTX
· Real-Time Price · USD
329.83
0.09 (0.03%)
At close: Mar 15, 2024, 9:00 PM
Karuna Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -26.26 | -13.37 | -19.72 | -18.36 | -22.18 | -26.35 | -14.56 | -16.4 | -34.77 | -17.76 | -24.41 | -27.39 |
PEG Ratio | 5.53 | -0.9 | -1.74 | -1.63 | -5.25 | 14.29 | -1.17 | -0.16 | 0.77 | -0.38 | -3.84 | -1.16 |
PS Ratio | n/a | n/a | n/a | 9.67K | 1.28K | 89.83K | 716.59 | n/a | 105.22 | n/a | n/a | n/a |
PB Ratio | 9.53 | 4.82 | 5.73 | 4.25 | 6.00 | 6.15 | 9.33 | 8.33 | 7.75 | 6.98 | 6.00 | 5.71 |
P/FCF Ratio | -106.9 | -57.61 | -125.36 | -62.37 | -85.53 | -121.03 | -94.67 | -76.2 | -500.74 | -79.81 | -113.41 | -157.39 |
P/OCF Ratio | -107.67 | -57.94 | -126.88 | -62.82 | -85.84 | -121.38 | -95.75 | -75.88 | -555.76 | -82.58 | -116.32 | -157.74 |
OCF/S Ratio | n/a | n/a | n/a | -153.87 | -14.92 | -740.07 | -7.48 | n/a | -0.19 | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | 0.00 |
Quick Ratio | 18.82 | 27.73 | 37.61 | 59.74 | 33.18 | 29.32 | 17.32 | 29.18 | 24.56 | 33.55 | 55.01 | 89.02 |
Current Ratio | 19.31 | 27.88 | 37.61 | 59.74 | 34.02 | 29.93 | 17.77 | 29.18 | 25.59 | 33.55 | 55.01 | 89.02 |
Asset Turnover | n/a | n/a | n/a | 0.00 | 0.00 | 0.00 | 0.01 | n/a | 0.07 | n/a | n/a | n/a |
Interest Coverage | -11.28 | n/a | n/a | n/a | -8.89 | -20.85 | -132.76 | -247.23 | n/a | n/a | n/a | n/a |
Return on Equity | -0.09 | -0.09 | -0.07 | -0.06 | -0.07 | -0.06 | -0.16 | -0.13 | -0.06 | -0.1 | -0.06 | -0.05 |
Return on Assets | -0.09 | -0.09 | -0.07 | -0.06 | -0.07 | -0.06 | -0.15 | -0.12 | -0.05 | -0.09 | -0.06 | -0.05 |
Return on Invested Capital | -0.1 | -0.1 | -0.08 | -0.06 | -0.08 | -0.06 | -0.16 | -0.13 | -0.06 | -0.1 | -0.06 | -0.05 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | 0.50 | 0.94 | -2.58 | 0.95 | n/a | 1.00 | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | -131.62 | -14.44 | -852.44 | -12.3 | n/a | -0.76 | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | -149.2 | -14.27 | -950.16 | -12.2 | n/a | -0.76 | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | -166.77 | -16.11 | -999.93 | -12.33 | n/a | -0.76 | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | -166.77 | -16.11 | -996.35 | -12.27 | n/a | -0.76 | n/a | n/a | n/a |